title: Ofatumumab in rituximab-refractory autoimmune hemolytic anemia associated with chronic lymphocytic leukemia: a case report and review of literature.
authors.affiliation: Department of Internal Medicine, Cooper University Hospital, Camden, NJ, USA. Nader-Kamyar@cooperhealth.edu
authors.forename: Kamyar
authors.initials: K
authors.lastname: Nader
authors.forename: Monaliben
authors.initials: M
authors.lastname: Patel
authors.forename: Andres
authors.initials: A
authors.lastname: Ferber
mesh_terms: D000368:Aged; D000744:Anemia, Hemolytic, Autoimmune / Q000150:complications / Q000188:drug therapy*; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D058846:Antibodies, Monoclonal, Murine-Derived; D005260:Female; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000150:complications / Q000188:drug therapy*; D000069283:Rituximab
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab; C527517:ofatumumab
keywords: Autoimmune hemolytic anemia; Chronic lymphocytic leukemia; Monoclonal antibody; Ofatumumab